FDA Drugs recall ·
Tirzepatide Inj, 15mg x 4, Sterile Multi-Dose Vial, Rx only, Nomida… recall
- Recall number
- D-0395-2026
- Date
- (initiated February 26, 2026)
- Company / brand
- New Life Pharma LLC
265 Livingston St, Northvale, NJ, United States - Category
- Drugs › Class II
- Classification
- Class II
- Status
- Ongoing
- Units affected
- 45 vials
- Hazard tags
- Sterility
- Initiated by
- Voluntary: Firm initiated
Read the official FDA notice ↗
Product
Tirzepatide Inj, 15mg x 4, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-002-04.
Why was it recalled?
Lack of Assurance of Sterility
What should you do?
FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.
Product codes & lot numbers
Lot 240709, exp 7/31/2026
Distribution
OH
What does Class II mean?
Class II means use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or the probability of serious harm is remote.
Source: FDA (drugs), recall D-0395-2026. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.